# Chlorambucil

## Leukeran 2mg

##### 臨採

| 標題       | 說明                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|:-----------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 藥品代碼   | OLEUK                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 適應症     | Management of chronic lymphocytic leukemia (CLL), Hodgkin lymphoma (HL) and non-Hodgkin lymphomas (NHL).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 用法用量   | Take daily on an empty stomach (at least 1 hour before meals or 3 hours after meals). May be used in the management of Hodgkin's disease and non- Hodgkin's lymphomas in children. The dosage regimens are similar to those used in adults.  [Hodgkin's disease] 0.2 mg/kg/day for 4-8 weeks as a single agent in the palliative treatment of advanced disease[Non-Hodgkin's lymphoma] 0.1-0.2 mg/kg/day as a single agent for 4-8 weeks initially; maintenance therapy is then given either by a reduced daily dosage or intermittent courses of treatment.  [Chronic lymphocytic leukaemia] 0.15 mg/kg/day initially until the total leukocyte count has fallen to 10,000/mL. Treatment may be resumed 4 weeks after the end of the first course and continued at a dosage of 0.1 mg/kg/day. [Waldenstrom's macroglobulinaema] Starting doses of 6-12 mg daily until leucopenia occurs are recommended followed by 2-8 mg daily indefinitely. |
| 肝功能異常 | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 腎功能異常 | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 禁忌       | Hypersensitivity to chlorambucil or any component of the formulation; hypersensitivity to other alkylating agents (may have cross-hypersensitivity); prior (demonstrated) resistance to chlorambucil. Canadian labeling: Additional contraindications (not in US labeling): Use within 4 weeks of a full course of radiation or chemotherapy.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 副作用     | Bone marrow suppression; GI disturbances. Occasionally: severe interstitial pulmonary fibrosis; hepatotoxicity & jaundice. Fever, skin hypersensitivity, peripheral neuropathy, interstitial pneumonia & sterile cystitis. Seizures.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 孕期建議   | No Data                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 哺乳期建議 | No (Limited) Human Data – Potential Toxicity(Mother) 無(很少)資料 – 避免使用(母體)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |

